Loading data for BANB.SW — first visit, this takes a few seconds.
Bachem Holding AG (BANB.SW)
Swiss: BANB.SW
· Real-Time Price · USD
75.80
+0.20 (0.26%)
At close: Aug 31, 2026, 5:19 PM
The price, the headline numbers and the latest news, in one place.
Bachem Holding AG (BANB.SW) Stock Price, Analysis & Data
0.26% (1D)
| Bid | 75.7 |
| Market Cap | 5.68B |
| Revenue (ttm) | 709M |
| Net Income (ttm) | 149M |
| 0.80 | |
| 1.98 | |
| 38.28 | |
| 24.94 | |
| P/B (ttm) | 3.94 |
| P/S (ttm) | 8.02 |
| Earnings Date | Mar 4, 2027 |
| Ask | 75.85 |
| Volume | 43,424 |
| Avg. Volume (20D) | 122,158 |
| Open | 75.80 |
| Previous Close | 75.60 |
| Day's Range | 75.40 - 76.90 |
| 52-Week Range | 48.52 - 83.25 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $0.90 (1.17%) |
| Ex-Dividend Date | May 4, 2026 |
About BANB.SW
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quali...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 17, 1998
Employees 2,725
Stock Exchange Swiss
Ticker Symbol BANB.SW
Website https://www.bachem.com
Financial Performance
In 2025, Bachem's revenue was 695.07M, an increase of 14.84% compared to the previous year's 605.26M. Earnings were 148.79M, an increase of 23.74%.
Financial numbers in CHF Financial StatementsEarnings Surprise
Bachem has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.
Bachem Holding AG is scheduled to release its earnings on Mar 4, 2027, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2